Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00793806 · ClinicalTrials.gov registry record
Immunologic Abnormalities, Chronic Inflammation and Oxidative Stress in Chronic Kidney Disease
A clinical trial of Chronic Kidney Disease, sponsored by University of California, Irvine.
- Completed
- Registry status
- 14
- Enrollment target
- 3
- Study locations
NCT00793806: Completed study of Chronic Kidney Disease, sponsored by University of California, Irvine.
NCT00793806 is a study of Chronic Kidney Disease that has completed, run by University of California, Irvine. The registered enrollment target is 14 participants, below the 3,207-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (100% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00793806, a study of Chronic Kidney Disease, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
- 3
- Study locations
Study Summary
The common causes of mortality are late stages of chronic kidney disease, cardiovascular disease and infections, are associated with abnormalities of the immune system, an underlying state of chronic inflammation and oxidative stress. These processes have not been carefully described in the chronic kidney disease population. The researcher can use Diffuse Optical Spectroscopy to determine the immune system in individuals with chronic kidney disease and describe the association with chronic inflammation and oxidative stress in that population.
Primary Outcome
Diffuse Optical Spectroscopy measure blood values changes during the hemodialysis treatment.
Conditions Studied
Interventions
- DEVICE Diffuse Optical Spectroscopy
Study Locations (3)
California
- Beckman Laser Institute - Irvine
- University of California Medical Center: Dialysis Unit - Orange
- UCIMC Dialysis center - Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2008-08 |
| Est. Completion | 2012-03 |
What the finished NCT00793806 record still lists
NCT00793806 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 3,207-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Chronic Kidney Disease appearing as the primary indexed condition, and to 1 intervention - of which Diffuse Optical Spectroscopy is the first listed.
NCT00793806 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00793806 about?
NCT00793806 is a clinical study titled "Immunologic Abnormalities, Chronic Inflammation and Oxidative Stress in Chronic Kidney Disease". The common causes of mortality are late stages of chronic kidney disease, cardiovascular disease and infections, are associated with abnormalities of the immune system, an underlying state of chronic inflammation and oxidative stress. These processes have not been carefully described in the chronic ...
What is the current status of trial NCT00793806?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2008-08. Estimated completion is 2012-03.
What conditions does trial NCT00793806 study?
This clinical trial studies the following conditions: Chronic Kidney Disease.
What interventions are being tested in trial NCT00793806?
The interventions under investigation include: Diffuse Optical Spectroscopy (DEVICE).
Who is sponsoring clinical trial NCT00793806?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00793806 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00793806's enrollment target sits among peer trials
14 97th of 101 higher than 4 of 101 other Chronic Kidney Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Kidney Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
RECRUITING · Phase 2
-
Patient-driven Management of BP in CKD
RECRUITING · Phase 3
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Pivotal Study of the Velocity™ pAVF System
RECRUITING · NA
-
Safety of Short-course of NSAIDs in Pediatric Patients With CKD
RECRUITING · Phase 4
-
Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia